Istituto Clinico Humanitas
Istituto Clinico Humanitas
Milan, Italy11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-09-30 | NCT06765109 | |
| A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer | HER2 positive breast carcinoma, Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-09-29 | NCT05132582 | |
| First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors | Select Advanced Solid Tumors | Recruiting | Phase 1 | 2026-09-24 | NCT06402201 | |
| A Post Approval Multicenter 10 Year Follow-up Observational Trial of Marketed Product - MP01 vs. Surgical Standard of Care (SSOC) Used for the Treatment of Joint Surface Lesions of the Knee | Knee Injuries, Leg Injuries, injury | Enrolling by invitation | Not stated | 2026-07-16 | NCT06916728 | |
| A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, cervical squamous cell carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-06-29 | NCT06747585 | |
| SNV1521 in Participants With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2026-06-25 | NCT06220864 | |
| Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) | Bladder Carcinoma in Situ (CIS) | Active, not recruiting | Phase 3 | 2026-06-23 | NCT05024773 | |
| Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 3 | 2026-06-08 | NCT05904119 | |
| Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer | Oligometastatic Squamous Cell Carcinoma of the Head and Neck | Recruiting | Phase 3 | 2026-05-28 | NCT05815927 | |
| Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, chordoma, neoplasm | Recruiting | Not applicable | 2026-01-02 | NCT02986516 | |
| E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe | cancer, neoplasm | Recruiting | Not stated | 2025-03-21 | NCT03818503 |